Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Single Center Single Arm Pilot Study Administering Danazol for Treatment of Cytopenias in Patients With Cirrhosis

NCT04873102 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT04873102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04873102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Single Center Single Arm Pilot Study Administering Danazol for Treatment of Cytopenias in Patients With Cirrhosis
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Recruiting
Start date
August 1, 2024
Completion date
August 1, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, cytopenia